Pre-order Enquiry
Request Free Sample
Global Fragile X Syndrome Market Insights, Forecast to 2025
SKU ID : QYR-13807004 | Publishing Date : 01-Feb-2019 | No. of pages : 110
Detailed TOC of Global Fragile X Syndrome Market Insights, Forecast to 2025
Table of Contents1 Study Coverage
1.1 Fragile X Syndrome Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Fragile X Syndrome Market Size Growth Rate by Product
1.4.2 ACT-01
1.4.3 AMO-01
1.4.4 ANAVEX-273
1.4.5 AUT-00206
1.4.6 Bryostatin-1
1.4.7 Cannabidiol
1.4.8 Others
1.5 Market by End User
1.5.1 Global Fragile X Syndrome Market Size Growth Rate by End User
1.5.2 Clinic
1.5.3 Hopital
1.5.4 Research Center
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Fragile X Syndrome Market Size
2.1.1 Global Fragile X Syndrome Revenue 2014-2025
2.1.2 Global Fragile X Syndrome Sales 2014-2025
2.2 Fragile X Syndrome Growth Rate by Regions
2.2.1 Global Fragile X Syndrome Sales by Regions
2.2.2 Global Fragile X Syndrome Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Fragile X Syndrome Sales by Manufacturers
3.1.1 Fragile X Syndrome Sales by Manufacturers
3.1.2 Fragile X Syndrome Sales Market Share by Manufacturers
3.1.3 Global Fragile X Syndrome Market Concentration Ratio (CR5 and HHI)
3.2 Fragile X Syndrome Revenue by Manufacturers
3.2.1 Fragile X Syndrome Revenue by Manufacturers (2014-2019)
3.2.2 Fragile X Syndrome Revenue Share by Manufacturers (2014-2019)
3.3 Fragile X Syndrome Price by Manufacturers
3.4 Fragile X Syndrome Manufacturing Base Distribution, Product Types
3.4.1 Fragile X Syndrome Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Fragile X Syndrome Product Type
3.4.3 Date of International Manufacturers Enter into Fragile X Syndrome Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Fragile X Syndrome Sales by Product
4.2 Global Fragile X Syndrome Revenue by Product
4.3 Fragile X Syndrome Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Fragile X Syndrome Breakdown Data by End User
6 North America
6.1 North America Fragile X Syndrome by Countries
6.1.1 North America Fragile X Syndrome Sales by Countries
6.1.2 North America Fragile X Syndrome Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Fragile X Syndrome by Product
6.3 North America Fragile X Syndrome by End User
7 Europe
7.1 Europe Fragile X Syndrome by Countries
7.1.1 Europe Fragile X Syndrome Sales by Countries
7.1.2 Europe Fragile X Syndrome Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Fragile X Syndrome by Product
7.3 Europe Fragile X Syndrome by End User
8 Asia Pacific
8.1 Asia Pacific Fragile X Syndrome by Countries
8.1.1 Asia Pacific Fragile X Syndrome Sales by Countries
8.1.2 Asia Pacific Fragile X Syndrome Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Fragile X Syndrome by Product
8.3 Asia Pacific Fragile X Syndrome by End User
9 Central & South America
9.1 Central & South America Fragile X Syndrome by Countries
9.1.1 Central & South America Fragile X Syndrome Sales by Countries
9.1.2 Central & South America Fragile X Syndrome Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Fragile X Syndrome by Product
9.3 Central & South America Fragile X Syndrome by End User
10 Middle East and Africa
10.1 Middle East and Africa Fragile X Syndrome by Countries
10.1.1 Middle East and Africa Fragile X Syndrome Sales by Countries
10.1.2 Middle East and Africa Fragile X Syndrome Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Fragile X Syndrome by Product
10.3 Middle East and Africa Fragile X Syndrome by End User
11 Company Profiles
11.1 Aelis Farma SAS
11.1.1 Aelis Farma SAS Company Details
11.1.2 Company Business Overview
11.1.3 Aelis Farma SAS Fragile X Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Aelis Farma SAS Fragile X Syndrome Products Offered
11.1.5 Aelis Farma SAS Recent Development
11.2 Alcobra Ltd
11.2.1 Alcobra Ltd Company Details
11.2.2 Company Business Overview
11.2.3 Alcobra Ltd Fragile X Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Alcobra Ltd Fragile X Syndrome Products Offered
11.2.5 Alcobra Ltd Recent Development
11.3 AMO Pharma Limited
11.3.1 AMO Pharma Limited Company Details
11.3.2 Company Business Overview
11.3.3 AMO Pharma Limited Fragile X Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.3.4 AMO Pharma Limited Fragile X Syndrome Products Offered
11.3.5 AMO Pharma Limited Recent Development
11.4 Confluence Pharmaceuticals LLC
11.4.1 Confluence Pharmaceuticals LLC Company Details
11.4.2 Company Business Overview
11.4.3 Confluence Pharmaceuticals LLC Fragile X Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Confluence Pharmaceuticals LLC Fragile X Syndrome Products Offered
11.4.5 Confluence Pharmaceuticals LLC Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Company Business Overview
11.5.3 Eli Lilly and Company Fragile X Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Eli Lilly and Company Fragile X Syndrome Products Offered
11.5.5 Eli Lilly and Company Recent Development
11.6 F. Hoffmann-La Roche Ltd.
11.6.1 F. Hoffmann-La Roche Ltd. Company Details
11.6.2 Company Business Overview
11.6.3 F. Hoffmann-La Roche Ltd. Fragile X Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.6.4 F. Hoffmann-La Roche Ltd. Fragile X Syndrome Products Offered
11.6.5 F. Hoffmann-La Roche Ltd. Recent Development
11.7 Marinus Pharmaceuticals, Inc.
11.7.1 Marinus Pharmaceuticals, Inc. Company Details
11.7.2 Company Business Overview
11.7.3 Marinus Pharmaceuticals, Inc. Fragile X Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Marinus Pharmaceuticals, Inc. Fragile X Syndrome Products Offered
11.7.5 Marinus Pharmaceuticals, Inc. Recent Development
11.8 MI.TO. Technology S.r.L.
11.8.1 MI.TO. Technology S.r.L. Company Details
11.8.2 Company Business Overview
11.8.3 MI.TO. Technology S.r.L. Fragile X Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.8.4 MI.TO. Technology S.r.L. Fragile X Syndrome Products Offered
11.8.5 MI.TO. Technology S.r.L. Recent Development
11.9 Neuren Pharmaceuticals Limited
11.9.1 Neuren Pharmaceuticals Limited Company Details
11.9.2 Company Business Overview
11.9.3 Neuren Pharmaceuticals Limited Fragile X Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Neuren Pharmaceuticals Limited Fragile X Syndrome Products Offered
11.9.5 Neuren Pharmaceuticals Limited Recent Development
11.10 Ovid Therapeutics Inc.
11.10.1 Ovid Therapeutics Inc. Company Details
11.10.2 Company Business Overview
11.10.3 Ovid Therapeutics Inc. Fragile X Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Ovid Therapeutics Inc. Fragile X Syndrome Products Offered
11.10.5 Ovid Therapeutics Inc. Recent Development
11.11 Sage Therapeutics, Inc.
11.12 Zynerba Pharmaceuticals, Inc.
12 Future Forecast
12.1 Fragile X Syndrome Market Forecast by Regions
12.1.1 Global Fragile X Syndrome Sales Forecast by Regions 2019-2025
12.1.2 Global Fragile X Syndrome Revenue Forecast by Regions 2019-2025
12.2 Fragile X Syndrome Market Forecast by Product
12.2.1 Global Fragile X Syndrome Sales Forecast by Product 2019-2025
12.2.2 Global Fragile X Syndrome Revenue Forecast by Product 2019-2025
12.3 Fragile X Syndrome Market Forecast by End User
12.4 North America Fragile X Syndrome Forecast
12.5 Europe Fragile X Syndrome Forecast
12.6 Asia Pacific Fragile X Syndrome Forecast
12.7 Central & South America Fragile X Syndrome Forecast
12.8 Middle East and Africa Fragile X Syndrome Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Fragile X Syndrome Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global Fragile X Syndrome Market Insights, Forecast to 2025
List of Tables and FiguresFigure Fragile X Syndrome Product Picture
Table Fragile X Syndrome Market Segments
Table Key Manufacturers Fragile X Syndrome Covered
Table Global Fragile X Syndrome Market Size Growth Rate by Product 2019-2025 (K Pcs) & (Million US$)
Figure Global Fragile X Syndrome Sales Market Share by Product 2014-2025
Figure ACT-01 Product Picture
Table Major Manufacturers of ACT-01
Figure AMO-01 Product Picture
Table Major Manufacturers of AMO-01
Figure ANAVEX-273 Product Picture
Table Major Manufacturers of ANAVEX-273
Figure AUT-00206 Product Picture
Table Major Manufacturers of AUT-00206
Figure Bryostatin-1 Product Picture
Table Major Manufacturers of Bryostatin-1
Figure Cannabidiol Product Picture
Table Major Manufacturers of Cannabidiol
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Fragile X Syndrome Market Size Growth Rate by End User 2019-2025 (K Pcs)
Figure Clinic
Figure Hopital
Figure Research Center
Figure Fragile X Syndrome Report Years Considered
Figure Global Fragile X Syndrome Market Size 2014-2025 (Million US$)
Figure Global Fragile X Syndrome Sales 2014-2025 (K Pcs)
Table Global Fragile X Syndrome Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Fragile X Syndrome Sales by Regions 2014-2019 (K Pcs)
Table Global Fragile X Syndrome Sales Market Share by Regions 2014-2019
Figure Global Fragile X Syndrome Sales Market Share by Regions 2014-2019
Figure 2018 Global Fragile X Syndrome Sales Market Share by Regions
Table Global Fragile X Syndrome Revenue by Regions 2014-2019 (Million US$)
Table Global Fragile X Syndrome Revenue Market Share by Regions 2014-2019
Figure Global Fragile X Syndrome Revenue Market Share by Regions 2014-2019
Figure 2018 Global Fragile X Syndrome Revenue Market Share by Regions
Table Global Fragile X Syndrome Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Fragile X Syndrome Sales Share by Manufacturers (2014-2019)
Figure Global Fragile X Syndrome Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Fragile X Syndrome Revenue by Manufacturers (2014-2019) (Million USD)
Table Fragile X Syndrome Revenue Share by Manufacturers (2014-2019)
Figure Fragile X Syndrome Value Share by Manufacturers in 2018
Table Key Manufacturers Fragile X Syndrome Price (2014-2019) (USD/Pcs)
Table Fragile X Syndrome Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Fragile X Syndrome Product Type
Table Date of International Manufacturers Enter into Fragile X Syndrome Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Fragile X Syndrome Sales by Product (2014-2019) (K Pcs)
Table Global Fragile X Syndrome Sales Share by Product (2014-2019)
Figure Global Fragile X Syndrome Sales Market Share by Product (2014-2019)
Figure Global Fragile X Syndrome Sales Market Share by Product in 2018
Table Global Fragile X Syndrome Revenue by Product (2014-2019) (Million US$)
Table Global Fragile X Syndrome Revenue Share by Product (2014-2019)
Figure Global Fragile X Syndrome Revenue Market Share by Product (2014-2019)
Figure Global Fragile X Syndrome Revenue Market Share by Product in 2018
Table Fragile X Syndrome Price by Product 2014-2019 (USD/Pcs)
Table Global Fragile X Syndrome Sales by End User (2014-2019) (K Pcs)
Table Global Fragile X Syndrome Sales Share by End User (2014-2019)
Figure Global Sales Fragile X Syndrome Market Share by End User (2014-2019)
Figure Global Sales Fragile X Syndrome Market Share by End User in 2018
Figure North America Fragile X Syndrome Sales Growth Rate 2014-2019 (K Pcs)
Figure North America Fragile X Syndrome Revenue Growth Rate 2014-2019 (Million US$)
Table North America Fragile X Syndrome Sales by Countries (2014-2019) (K Pcs)
Table North America Fragile X Syndrome Sales Market Share by Countries (2014-2019)
Figure 2018 North America Fragile X Syndrome Sales Market Share by Countries
Table North America Fragile X Syndrome Revenue by Countries (2014-2019) (Million US$)
Table North America Fragile X Syndrome Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Fragile X Syndrome Revenue Market Share by Countries
Figure United States Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure United States Fragile X Syndrome Revenue Growth Rate (2014-2019) (K Pcs)
Figure Canada Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Canada Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Mexico Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Table North America Fragile X Syndrome Sales by Product (2014-2019) (K Pcs)
Table North America Fragile X Syndrome Sales Market Share by Product (2014-2019)
Figure 2018 North America Fragile X Syndrome Market Share by Product
Table North America Fragile X Syndrome Sales by End User (2014-2019) (K Pcs)
Table North America Fragile X Syndrome Sales Market Share by End User (2014-2019)
Figure 2018 North America Fragile X Syndrome Market Share by End User
Figure Europe Fragile X Syndrome Sales Growth Rate 2014-2019 (K Pcs)
Figure Europe Fragile X Syndrome Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Fragile X Syndrome Sales by Countries (2014-2019) (K Pcs)
Table Europe Fragile X Syndrome Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Fragile X Syndrome Sales Market Share by Countries
Table Europe Fragile X Syndrome Revenue by Countries (2014-2019) (Million US$)
Table Europe Fragile X Syndrome Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Fragile X Syndrome Revenue Market Share by Countries
Figure Germany Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Germany Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure France Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure France Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure UK Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Italy Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Russia Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Fragile X Syndrome Sales by Product (2014-2019) (K Pcs)
Table Europe Fragile X Syndrome Sales Market Share by Product (2014-2019)
Figure 2018 Europe Fragile X Syndrome Market Share by Product
Table Europe Fragile X Syndrome Sales by End User (2014-2019) (K Pcs)
Table Europe Fragile X Syndrome Sales Market Share by End User (2014-2019)
Figure 2018 Europe Fragile X Syndrome Market Share by End User
Figure Asia Pacific Fragile X Syndrome Sales Growth Rate 2014-2019 (K Pcs)
Figure Asia Pacific Fragile X Syndrome Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Fragile X Syndrome Sales by Countries (2014-2019) (K Pcs)
Table Asia Pacific Fragile X Syndrome Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Fragile X Syndrome Sales Market Share by Countries
Table Asia Pacific Fragile X Syndrome Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Fragile X Syndrome Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Fragile X Syndrome Revenue Market Share by Countries
Figure China Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure China Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure India Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure India Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Australia Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Indonesia Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Malaysia Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Philippines Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Thailand Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Vietnam Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Singapore Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Fragile X Syndrome Sales by Product (2014-2019) (K Pcs)
Table Asia Pacific Fragile X Syndrome Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Fragile X Syndrome Market Share by Product
Table Asia Pacific Fragile X Syndrome Sales by End User (2014-2019) (K Pcs)
Table Asia Pacific Fragile X Syndrome Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Fragile X Syndrome Market Share by End User
Figure Central & South America Fragile X Syndrome Sales Growth Rate 2014-2019 (K Pcs)
Figure Central & South America Fragile X Syndrome Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Fragile X Syndrome Sales by Countries (2014-2019) (K Pcs)
Table Central & South America Fragile X Syndrome Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Fragile X Syndrome Sales Market Share by Countries
Table Central & South America Fragile X Syndrome Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Fragile X Syndrome Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Fragile X Syndrome Revenue Market Share by Countries
Figure Brazil Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Brazil Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Argentina Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Fragile X Syndrome Sales by Product (2014-2019) (K Pcs)
Table Central & South America Fragile X Syndrome Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Fragile X Syndrome Market Share by Product
Table Central & South America Fragile X Syndrome Sales by End User (2014-2019) (K Pcs)
Table Central & South America Fragile X Syndrome Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Fragile X Syndrome Market Share by End User
Figure Middle East and Africa Fragile X Syndrome Sales Growth Rate 2014-2019 (K Pcs)
Figure Middle East and Africa Fragile X Syndrome Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Fragile X Syndrome Sales by Countries (2014-2019) (K Pcs)
Table Middle East and Africa Fragile X Syndrome Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Fragile X Syndrome Sales Market Share by Countries
Table Middle East and Africa Fragile X Syndrome Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Fragile X Syndrome Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Fragile X Syndrome Revenue Market Share by Countries
Figure GCC Countries Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure GCC Countries Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Turkey Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure Egypt Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Fragile X Syndrome Sales Growth Rate (2014-2019) (K Pcs)
Figure South Africa Fragile X Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Fragile X Syndrome Sales by Product (2014-2019) (K Pcs)
Table Middle East and Africa Fragile X Syndrome Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Fragile X Syndrome Market Share by Product
Table Middle East and Africa Fragile X Syndrome Sales by End User (2014-2019) (K Pcs)
Table Middle East and Africa Fragile X Syndrome Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Fragile X Syndrome Market Share by End User
Table Aelis Farma SAS Company Details
Table Aelis Farma SAS Fragile X Syndrome Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aelis Farma SAS Recent Development
Table Alcobra Ltd Company Details
Table Alcobra Ltd Fragile X Syndrome Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alcobra Ltd Recent Development
Table AMO Pharma Limited Company Details
Table AMO Pharma Limited Fragile X Syndrome Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table AMO Pharma Limited Recent Development
Table Confluence Pharmaceuticals LLC Company Details
Table Confluence Pharmaceuticals LLC Fragile X Syndrome Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Confluence Pharmaceuticals LLC Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Fragile X Syndrome Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly and Company Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Fragile X Syndrome Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Marinus Pharmaceuticals, Inc. Company Details
Table Marinus Pharmaceuticals, Inc. Fragile X Syndrome Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Marinus Pharmaceuticals, Inc. Recent Development
Table MI.TO. Technology S.r.L. Company Details
Table MI.TO. Technology S.r.L. Fragile X Syndrome Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table MI.TO. Technology S.r.L. Recent Development
Table Neuren Pharmaceuticals Limited Company Details
Table Neuren Pharmaceuticals Limited Fragile X Syndrome Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Neuren Pharmaceuticals Limited Recent Development
Table Ovid Therapeutics Inc. Company Details
Table Ovid Therapeutics Inc. Fragile X Syndrome Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ovid Therapeutics Inc. Recent Development
Table Sage Therapeutics, Inc. Company Details
Table Zynerba Pharmaceuticals, Inc. Company Details
Table Global Fragile X Syndrome Sales Forecast by Regions 2019-2025 (K Pcs)
Table Global Fragile X Syndrome Sales Market Share Forecast by Regions 2019-2025
Table Global Fragile X Syndrome Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Fragile X Syndrome Revenue Market Share Forecast by Regions 2019-2025
Table Global Fragile X Syndrome Sales Forecast by Product 2019-2025 (K Pcs)
Table Global Fragile X Syndrome Sales Market Share Forecast by Product 2019-2025
Table Global Fragile X Syndrome Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Fragile X Syndrome Revenue Market Share Forecast by Product 2019-2025
Table Global Fragile X Syndrome Sales Forecast by End User 2019-2025 (K Pcs)
Table Global Fragile X Syndrome Sales Market Share Forecast by End User 2019-2025
Figure North America Fragile X Syndrome Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure North America Fragile X Syndrome Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Fragile X Syndrome Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Europe Fragile X Syndrome Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Fragile X Syndrome Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Asia Pacific Fragile X Syndrome Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Fragile X Syndrome Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Central & South America Fragile X Syndrome Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Fragile X Syndrome Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Middle East and Africa Fragile X Syndrome Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Fragile X Syndrome Value Chain
Table Fragile X Syndrome Customers List
Table Fragile X Syndrome Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Fragile X Syndrome Market Insights, Forecast to 2025
Aelis Farma SASAlcobra Ltd
AMO Pharma Limited
Confluence Pharmaceuticals LLC
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Marinus Pharmaceuticals, Inc.
MI.TO. Technology S.r.L.
Neuren Pharmaceuticals Limited
Ovid Therapeutics Inc.
Sage Therapeutics, Inc.
Zynerba Pharmaceuticals, Inc.
Request Sample
Request Discount
